In line with these results, western blot analysis indicated that while FNDC3B overexpression was observed in all GBM cell lines (U87-IDH mutant, U87MG, U251, T98G), its expression was relatively low in cell lines from prostate cancer (PC3) and breast cancer (MCF7) (Figure 2a). Here, FNDC3B is linked to Familial prostate cancer.